FilingIndex
← The Wire
BEAMNasdaq

Beam Therapeutics Inc.

Biological Products, (No Diagnostic Substances) · DE · CIK 1745999

Beam Therapeutics develops precision genetic medicines using base editing technology for lifelong cures

$2.99B
Market cap
$34.95
Last close
+0.4%
1D
-1.6%
5D
2.9M
Volume
Price · last 39 sessions+16.2%
May 4L $26.33 · H $35.53Jun 29
132
Total filings
Jun 8, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 8, 202610-Q10-QMay 7, 20268-KResults of OperationsMay 7, 2026DEFA14ADEFA14AApr 17, 2026DEF 14ADEF 14AApr 17, 20268-KAgreement TerminatedMar 5, 202610-K10-KFeb 24, 20268-KMaterial Agreement · Results of OperationsFeb 24, 20268-KMaterial AgreementFeb 12, 20268-KExecutive ChangeFeb 5, 20268-KResults of Operations · Reg FD DisclosureJan 12, 20268-KAcquisition / DispositionDec 11, 202510-Q10-QNov 4, 20258-KResults of OperationsNov 4, 202510-Q10-QAug 5, 20258-KResults of OperationsAug 5, 20258-KEquity IssuanceJul 3, 20258-KShareholder VoteJun 6, 202510-Q10-QMay 6, 20258-KResults of OperationsMay 6, 2025DEFA14ADEFA14AApr 18, 2025DEF 14ADEF 14AApr 18, 2025424B5424B5Mar 10, 20258-KMaterial Agreement · Company UpdateMar 10, 2025424B5424B5Mar 10, 20258-KReg FD Disclosure · Company UpdateMar 10, 202510-K10-KFeb 25, 20258-KResults of OperationsFeb 25, 20258-KResults of Operations · Reg FD DisclosureJan 13, 20258-KReg FD Disclosure · Company UpdateDec 9, 20248-KExecutive Change · Reg FD DisclosureDec 6, 20248-KExecutive Change · Reg FD DisclosureDec 4, 202410-Q10-QNov 5, 20248-KCompany UpdateNov 5, 20248-KReg FD DisclosureNov 5, 20248-KResults of OperationsNov 5, 202410-Q10-QAug 6, 20248-KResults of OperationsAug 6, 20248-KExecutive ChangeJul 15, 20248-KShareholder VoteJun 10, 202410-Q10-QMay 7, 20248-KResults of OperationsMay 7, 2024DEFA14ADEFA14AApr 19, 2024DEF 14ADEF 14AApr 19, 202410-K10-KFeb 27, 20248-KResults of OperationsFeb 27, 2024SC 13GSC 13GJan 24, 20248-KResults of Operations · Reg FD DisclosureJan 8, 20248-KExecutive ChangeDec 14, 202310-Q10-QNov 8, 20238-KResults of OperationsNov 8, 20238-KAcquisition / Disposition · Equity IssuanceOct 31, 20238-KExit / Disposal Costs · Reg FD DisclosureOct 19, 2023SC 13GSC 13GSep 22, 202310-Q10-QAug 8, 20238-KResults of OperationsAug 8, 20238-KShareholder VoteJun 8, 2023424B5424B5May 10, 20238-KMaterial AgreementMay 10, 202310-Q10-QMay 10, 20238-KResults of OperationsMay 10, 2023DEFA14ADEFA14AApr 21, 2023DEF 14ADEF 14AApr 21, 2023SC 13GSC 13GMar 17, 202310-K10-KFeb 28, 20238-KResults of OperationsFeb 28, 20238-KResults of Operations · Reg FD DisclosureJan 9, 202310-Q10-QNov 7, 20228-KResults of OperationsNov 7, 20228-KCompany UpdateSep 7, 20228-KCompany UpdateAug 30, 202210-Q10-QAug 9, 20228-KResults of OperationsAug 9, 20228-KCompany UpdateAug 1, 2022SC 13GINITIAL 13GJul 14, 20228-KShareholder VoteJun 10, 202210-Q10-QMay 9, 20228-KResults of OperationsMay 9, 2022DEFA14ADEFA14AApr 22, 2022DEF 14ADEF 14AApr 22, 2022

Insider Activity

In the 90 days to Feb 24, 2026: 5 sold $3.8M.

DateInsiderActionSharesPriceValue
Feb 24, 2026Ciaramella GiuseppePresidentSell35,000$32.00$1.1M
Jan 30, 2026Evans John M.CEOSell22,094$28.27$625K
Jan 30, 2026Evans John M.CEOSell2,906$29.00$84K
Jan 29, 2026Evans John M.CEOSell16,333$29.19$477K
Jan 29, 2026Evans John M.CEOSell8,667$29.74$258K
Jan 22, 2026Cavanagh Bethany JSVP, Finance and TreasurerSell6,198$35.00$217K
Jan 22, 2026Bellon ChristineChief Legal OfficerSell1,371$34.00$47K
Jan 20, 2026Cavanagh Bethany JSVP, Finance and TreasurerSell3,034$30.12$91K
Jan 15, 2026Bellon ChristineChief Legal OfficerSell15,959$34.72$554K
Jan 15, 2026Bellon ChristineChief Legal OfficerSell2,111$33.62$71K
Jan 15, 2026Bellon ChristineChief Legal OfficerSell559$35.40$20K
Dec 31, 2025Emany Sravan KumarChief Financial OfficerSell6,294$27.10$171K
Dec 31, 2025Bellon ChristineChief Legal OfficerSell1,254$27.10$34K
Oct 27, 2025Fmr LlcTenPercentOwner,OtherSell459$26.68$12K
Oct 2, 2025Evans John M.CEOSell25,000$24.63$616K
Oct 1, 2025Evans John M.CEOSell25,000$24.51$613K
Oct 1, 2025Cavanagh Bethany JSVP, Finance and TreasurerSell467$24.53$11K
Oct 1, 2025Bellon ChristineChief Legal OfficerSell373$24.53$9K

Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.

Similar companies

Comparable business profile · signals at a glance